Financial Architects (New Jersey)’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Financial Architects (New Jersey)’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-44	Closed	–	–	1664
2017 Q1	$0	Hold	44	–	–	﹤0.01%	1649
2016 Q4	$1K	Hold	44	–	–	﹤0.01%	1368
2016 Q3	$5K	Hold	44	–	–	﹤0.01%	1163
2016 Q2	$3K	Hold	44	–	–	﹤0.01%	1252
2016 Q1	$3K	Buy	+44	New	+$2.8K	﹤0.01%	1005
2015 Q3	–	Sell	-19	Closed	-$2K	–	990
2015 Q2	$2K	Buy	+19	New	+$1.97K	﹤0.01%	1123
2014 Q4	–	Sell	-19	Closed	-$1K	–	1058
2014 Q3	$1K	Hold	19	–	–	﹤0.01%	867
2014 Q2	$1K	Buy	+19	New	+$1.48K	﹤0.01%	892

Other funds holding PLXP

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

HWA

Heritage Way Advisors Rockford, Illinois $267M AUM 23.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Financial Architects (New Jersey)'s PLXP Position: Q2 2017 in Review

Financial Architects (New Jersey) sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2017, closing a stake of 44 shares.

Financial Architects (New Jersey) first reported a position in PLXP in Q2 2014 and held it in 8 quarters. The position peaked at $5K in Q3 2016. 14 funds tracked by Wall St. Rank hold PLXP as of Q2 2017.

Financial Architects (New Jersey) reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
Financial Architects (New Jersey) sold 44 PLx Pharma Inc. Common Stock shares in Q2 2017.
Financial Architects (New Jersey) first reported a position in PLx Pharma Inc. Common Stock in Q2 2014 and held it in 8 quarters.
Financial Architects (New Jersey)'s PLx Pharma Inc. Common Stock position peaked at $5K in Q3 2016.
14 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2017.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2017, filed 21 Jul 2017.